The French Levothyrox® crisis: We did the best we could but…

Therapie. 2019 Jun;74(3):431-435. doi: 10.1016/j.therap.2019.01.003. Epub 2019 Jan 19.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Drug Compounding
  • France
  • Humans
  • Pharmacovigilance
  • Thyroxine / adverse effects*
  • Thyroxine / chemistry*
  • Thyroxine / therapeutic use

Substances

  • Thyroxine